EUVIMEDEUVIMED entdecken
Klinische Studie (Phase II)Klinische Studie (Phase I)Open Access · CC BY 4.0

Nasal septum-derived chondroprogenitor cells control mandibular condylar resorption consequent to orthognathic surgery: a clinical trial

Ricardo de Souza Tesch iD, Esther Rieko Takamori, Karla Menezes, Rosana Bizon Vieira Carias, Carmen Lucia Kuniyoshi Rebelatto, Alexandra Cristina Senegaglia, Debora Regina Daga, Leticia Fracaro, Anny Waloski Robert, Carlos Bruno Reis Pinheiro, Marcelo de Freitas Aguiar, Pablo Javier Blanco und 3 weitere

Stem Cells Translational Medicine · 2024

DOI: 10.1093/stcltm/szae026 ↗

Kurz gefasst

Klinische Studie (Phase II) in der Zeitschrift Stem Cells Translational Medicine, 2024. Verfasst von Ricardo de Souza Tesch und 14 weiteren Autor:innen. Beteiligte Einrichtung: Regenerative Medicine Laboratory, Petrópolis Medical School/ UNIFASE, Avenida Barão do Rio Branco 1003, Centro, Petrópolis, RJ 25680-120, Brazil. Hauptthemen laut MEDLINE: Nasal Septum, Mandibular Condyle. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Octacilio Gualberto Foundation (FOG), Rio de Janeiro State Research Support Foundation (FAPERJ).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Condylar resorption is an aggressive and disability form of temporomandibular joint (TMJ) degenerative disease, usually non-respondent to conservative or minimally invasive therapies and often leading to surgical intervention and prostheses implantation. This condition is also one of the most dreaded postoperative complications of orthognathic surgery, with severe cartilage erosion and loss of subchondral bone volume and mineral density, associated with a painful or not inflammatory processes. Because regenerative medicine has emerged as an alternative for orthopedic cases with advanced degenerative joint disease, we conducted a phase I/IIa clinical trial (U1111-1194-6997) to evaluate the safety and efficacy of autologous nasal septal chondroprogenitor cells. Ten participants underwent biopsy of the nasal septum cartilage during their orthognathic surgery. The harvested cells were cultured in vitro and analyzed for viability, presence of phenotype markers for mesenchymal stem and/or chondroprogenitor cells, and the potential to differentiate into chondrocytes, adipocytes, and osteoblasts. After the intra-articular injection of the cell therapy, clinical follow-up was performed using the Diagnostic Criteria for Temporomandibular Disorders (DC/TMD) and computed tomography (CT) images. No serious adverse events related to the cell therapy injection were observed during the 12-month follow-up period. It was found that autologous chondroprogenitors reduced arthralgia, promoted stabilization of mandibular function and condylar volume, and regeneration of condylar tissues. This study demonstrates that chondroprogenitor cells from the nasal septum may be a promise strategy for the treatment of temporomandibular degenerative joint disease that do not respond to other conservative therapies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Nasal SeptumMandibular CondyleHumansFemaleMaleAdultTemporomandibular Joint DisordersOrthognathic SurgeryChondrocytesCell DifferentiationBone ResorptionMesenchymal Stem Cells

Stichwörter der Autor:innen

cellular therapyclinical translationalprogenitor cellsskeleton

Autor:innen und Institutionen

  • Regenerative Medicine Laboratory, Petrópolis Medical School/ UNIFASE, Avenida Barão do Rio Branco 1003, Centro, Petrópolis, RJ 25680-120, Brazil.
  • Institute of Biomedical Sciences, Federal University of Rio de Janeiro, Ave. Carlos Chagas Filho 373, Sala B1-011, Cidade Universitária, Ilha Do Fundão, Rio de Janeiro, RJ 21941-590, Brazil.
  • Core for Cell Technology, School of Medicine and Life Sciences, Pontifícia Universidade Católica do Paraná, Prado Velho, Curitiba, PR 80215-901, Brazil.
  • Stem Cells Basic Biology Laboratory, Carlos Chagas Institute - FIOCRUZ/PR, Rua Professor Algacyr Munhoz Mader, 3775, Curitiba, PR, 81350-010, Brazil.
  • Postgraduate Program in Exercise and Sport Sciences, State University of Rio de Janeiro, Rua São Francisco Xavier 524, Maracanã, Rio de Janeiro, RJ, 20550-013, Brazil.
  • Department of Specific Formation, School of Dentistry, Health Institute of Nova Friburgo, Fluminense Federal University, Rua Dr. Silvio Henrique Braune, 22, Nova Friburgo, RJ, 28625-650, Brazil.

ORCID-Profile: Ricardo de Souza Tesch

Förderung

  • Octacilio Gualberto Foundation (FOG)
  • Rio de Janeiro State Research Support Foundation (FAPERJ)

Zitieren

APA

Tesch, R. S., Takamori, E. R., Menezes, K., Carias, R. B. V., Rebelatto, C. L. K., Senegaglia, A. C., Daga, D. R., Fracaro, L., Robert, A. W., Pinheiro, C. B. R., Aguiar, M. F., Blanco, P. J., Zilves, E. G., Brofman, P. R. S., & Borojevic, R. (2024). Nasal septum-derived chondroprogenitor cells control mandibular condylar resorption consequent to orthognathic surgery: a clinical trial. Stem Cells Translational Medicine. https://doi.org/10.1093/stcltm/szae026

Vancouver

Tesch RS, Takamori ER, Menezes K, Carias RBV, Rebelatto CLK, Senegaglia AC, et al. Nasal septum-derived chondroprogenitor cells control mandibular condylar resorption consequent to orthognathic surgery: a clinical trial. Stem Cells Translational Medicine. 2024. doi:10.1093/stcltm/szae026

BibTeX
@article{Tesch2024,
  author = {Tesch, Ricardo de Souza and Takamori, Esther Rieko and Menezes, Karla and Carias, Rosana Bizon Vieira and Rebelatto, Carmen Lucia Kuniyoshi and Senegaglia, Alexandra Cristina and Daga, Debora Regina and Fracaro, Leticia and Robert, Anny Waloski and Pinheiro, Carlos Bruno Reis and Aguiar, Marcelo de Freitas and Blanco, Pablo Javier and Zilves, Eduardo Guerreiro and Brofman, Paulo Roberto Slud and Borojevic, Radovan},
  title = {Nasal septum-derived chondroprogenitor cells control mandibular condylar resorption consequent to orthognathic surgery: a clinical trial},
  journal = {Stem Cells Translational Medicine},
  year = {2024},
  doi = {10.1093/stcltm/szae026}
}
Kostenlos starten →